NewAmsterdam Pharma Company N.V. (NAMS)

Price & Market Data

Price: $38.89

Daily Change: -$0.70 / 1.80%

Daily Range: $38.28 - $39.74

Market Cap: $4,546,395,648

Daily Volume: 2,069,141

Performance Metrics

1 Week: 30.28%

1 Month: 7.28%

3 Months: 11.46%

6 Months: 5.79%

1 Year: 102.3%

YTD: 10.86%

About NewAmsterdam Pharma Company N.V. (NAMS)

Stay informed about NewAmsterdam Pharma Company N.V. (NAMS). Price: 38.89, daily change: -$0.70 / 1.80%. Market cap: 4,546,395,648. Detailed performance for all key periods.

Company Details

Employees: 100

Sector: Health technology

Industry: Pharmaceuticals: major

Country: Netherlands

Details

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.

Selected stocks

Northern Technologies International Corporation (NTIC)

Sizzle Acquisition Corp. II (SZZLU)

Commvault Systems, Inc. (CVLT)

Republic Digital Acquisition Company (RDAG)

Dillard's Capital Trust I (DDT)